Linden Thomas Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Buy |
47,527
+1,630
| +4% | +$181K | 0.58% | 29 |
|
|
2025
Q1 | $5.14M | Buy |
45,897
+1,366
| +3% | +$153K | 0.67% | 18 |
|
|
2024
Q4 | $4.11M | Buy |
44,531
+1,630
| +4% | +$151K | 0.52% | 28 |
|
|
2024
Q3 | $3.6M | Buy |
42,901
+847
| +2% | +$71K | 0.49% | 36 |
|
|
2024
Q2 | $2.89M | Buy |
42,054
+7,084
| +20% | +$486K | 0.45% | 44 |
|
|
2024
Q1 | $2.56M | Buy |
34,970
+836
| +2% | +$61.2K | 0.41% | 47 |
|
|
2023
Q4 | $2.77M | Buy |
34,134
+2,153
| +7% | +$174K | 0.52% | 27 |
|
|
2023
Q3 | $2.4M | Buy |
31,981
+10,511
| +49% | +$788K | 0.53% | 22 |
|
|
2023
Q2 | $1.65M | Buy |
21,470
+594
| +3% | +$45.8K | 0.37% | 75 |
|
|
2023
Q1 | $1.73M | Buy |
20,876
+2,048
| +11% | +$170K | 0.43% | 63 |
|
|
2022
Q4 | $1.62M | Buy |
+18,828
| New | +$1.62M | 0.46% | 61 |
|